What is GME's health score?

GameStop Corp. (GME) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GME's estimated fair value?

Based on our 5-year discounted cash flow model, GameStop Corp.'s estimated fair value is $13.95 per share, representing a -33.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GME undervalued or overvalued?

Our model currently rates GME as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GME... Refresh in a moment for the full analysis.

GameStop Corp. (GME)

Consumer Cyclical Overvalued low healthy

$20.92

Updated: 2026-06-03

TradeApes Score

Financial Strength

80 Strong

Operating Trend

50 Mixed

Relative Value

65 Healthy

Capital Allocation

25 Stressed

Risk

70 Healthy

Est. Fair Value $13.95

DCF Upside -33.3%

Sector Rank #208 of 3247

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.